Search

Author/Creator Locatelli, F.

1. 3232 Synergistic cytotoxic effects of bortezomib and ck2 inhibitor cx-4945 in acute lymphoblastic leukemia: turning off the prosurvival er chaperone BIP/GRP78 and turning on the proapoptotic NF-κb. (September 2015)

Authors:
Buontempo, F.; Orsini, E.; Lonetti, A.; Cappellini, A.; Chiarini, F.; Evangelisti, Camilla; Evangelisti, Cecilia; Pession, A.; Bertaina, A.; Locatelli, F.; McCubrey, J.; Martelli, A.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S659
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 48 GATA2-RELATED MYELODYSPLASTIC SYNDROMES (MDS): PREVALENCE, CLINICAL CHARACTERISTICS AND PROGNOSIS. (April 2015)

Authors:
Wlodarski, M.; Hirabayashi, S.; Pastor, V.; Stary, J.; Hasle, H.; Masetti, R.; Dworzak, M.; Schmugge, M.; van den Heuvel-Eibrink, M.; De Moerloose, B.; Ussowicz, M.; Catala, A.; Smith, O.; Goehring, G.; Schlegelberger, B.; Locatelli, F.; Makishima, H.; Maciejewski, J.; Strahm, B.; Niemeyer, C.
Journal:
Leukemia research
Issue:
Volume 39(2015:Apr.) Supplement 1
Page Start:
S22
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A PHASE 1/2 STUDY OF BRENTUXIMAB VEDOTIN IN PEDIATRIC PATIENTS WITH RELAPSED/REFRACTORY (R/R) SYSTEMIC ANAPLASTIC LARGE‐CELL LYMPHOMA (SALCL) OR R/R HODGKIN LYMPHOMA (HL). (June 2017)

Authors:
Locatelli, F.; Mauz‐Koerholz, C.; Neville, K.; Llort, A.; Beishuizen, A.; Daw, S.; Pillon, M.; Aladjidi, N.; Klingebiel, T.; Landman‐Parker, J.; Medina‐Sanson, A.; August, K.; Huebner, D.; Sachs, J.; Hoffman, K.; Kinley, J.; Song, S.; Song, G.; Zhang, S.; Gore, L.
Journal:
Hematological oncology
Issue:
Volume 35(2017)Supplement 2
Page Start:
248
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗